Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Geriatrics
• Body Composition Analysis

Background:

• Chronic Obstructive Pulmonary Disease (COPD) involves progressive airflow limitation.
• Factors like age, sex, and toxin exposure affect pulmonary function.
• The specific impact of body composition and sarcopenia on COPD lung function remains unclear.

Purpose of the Study:

• To investigate the relationship between body composition compartments, sarcopenia, and pulmonary function in COPD patients.
• To determine if specific body composition metrics are associated with lung function parameters in COPD.

Main Methods:

• A cross-sectional study included 185 COPD patients (age > 40, FEV1/FVC < 0.70).
• Exclusion criteria: cancer, HIV, asthma.
• Body composition was assessed using bioelectrical impedance; sarcopenia was defined by EWGSOP2 criteria; pulmonary function was measured via spirometry.

Main Results:

• Linear regression revealed associations between body mass index, fat-free mass, skeletal muscle mass index (SMMI), appendicular skeletal muscle mass index (ASMMI), and phase angle (PhA) with FEV1 (%).
• Sarcopenia was also associated with FEV1 (%).
• PhA and exercise tolerance showed positive associations with FVC (%).

Conclusions:

• Body composition metrics, particularly PhA, SMMI, ASMMI, and sarcopenia, significantly influence pulmonary function in COPD.
• Early identification of body composition disturbances can guide timely therapeutic interventions for COPD patients.